Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AA.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.47NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.182NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.218NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.12.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.22 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.128NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.33NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.405NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.296NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.412NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AC.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.27NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.421NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.364NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.82NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.61NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.47NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.38NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.251NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.144NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.288NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.249NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.378NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17507.2China
B.1.97NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.439NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.408NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.256NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.7 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.460NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.262NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBUNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.351.5 (Beta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FZ.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.9.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBC.1.6.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.4.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FQ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JB.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.3.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FZ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.7.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.30.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.68NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used